TA
ESPR

Teachers Advisors’s Esperion Therapeutics ESPR Stock Holding History

Teachers Advisors’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.61M Buy
64,998
+401
+0.6% +$18K ﹤0.01% 1819
2018
Q4 		$2.97M Buy
64,597
+2,120
+3% +$102K ﹤0.01% 1606
2018
Q3 		$2.77M Buy
62,477
+16,237
+35% +$745K ﹤0.01% 1794
2018
Q2 		$1.81M Buy
46,240
+9,769
+27% +$494K ﹤0.01% 2004
2018
Q1 		$2.64M Sell
36,471
-111,936
-75% -$8.22M ﹤0.01% 1653
2017
Q4 		$9.77M Buy
148,407
+5,426
+4% +$292K 0.01% 1047
2017
Q3 		$7.17M Buy
142,981
+498
+0.3% +$24K 0.01% 1167
2017
Q2 		$6.59M Buy
142,483
+112,920
+382% +$4.15M 0.01% 1193
2017
Q1 		$1.04M Sell
29,563
-3,939
-12% -$90.2K ﹤0.01% 2164
2016
Q4 		$419K Buy
33,502
+12,122
+57% +$144K ﹤0.01% 2626
2016
Q3 		$296K Hold
21,380
– – ﹤0.01% 2718
2016
Q2 		$211K Buy
21,380
+1,942
+10% +$32.2K ﹤0.01% 2882
2016
Q1 		$329K Hold
19,438
– – ﹤0.01% 2560
2015
Q4 		$433K Hold
19,438
– – ﹤0.01% 2494
2015
Q3 		$459K Buy
19,438
+347
+2% +$21.8K ﹤0.01% 2451
2015
Q2 		$1.56M Buy
19,091
+11,083
+138% +$1.08M ﹤0.01% 1857
2015
Q1 		$742K Buy
8,008
+2,031
+34% +$131K ﹤0.01% 2218
2014
Q4 		$242K Hold
5,977
– – ﹤0.01% 2825
2014
Q3 		$146K Hold
5,977
– – ﹤0.01% 2982
2014
Q2 		$95K Buy
5,977
+1,727
+41% +$25K ﹤0.01% 3048
2014
Q1 		$64K Hold
4,250
– – ﹤0.01% 3063
2013
Q4 		$58K Hold
4,250
– – ﹤0.01% 3063
2013
Q3 		$80K Buy
+4,250
New +$71.4K ﹤0.01% 3023

Other funds holding ESPR

BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Teachers Advisors's ESPR Position: Q1 2019 in Review

Teachers Advisors increased its Esperion Therapeutics (ESPR) stake by 0.62% in Q1 2019, buying an estimated $18K and bringing the position to 64,998 shares worth $2.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1819.

Teachers Advisors first reported a position in ESPR in Q3 2013 and has held it in 23 quarters since. The position peaked at $9.77M in Q4 2017. 163 funds tracked by Wall St. Rank hold ESPR as of Q1 2019.

  • Teachers Advisors held 64,998 shares of Esperion Therapeutics worth $2.61M as of Q1 2019.
  • Teachers Advisors bought 401 Esperion Therapeutics shares in Q1 2019, an estimated $18K.
  • Esperion Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1819 holding.
  • Teachers Advisors first reported a position in Esperion Therapeutics in Q3 2013 and has held it in 23 quarters since.
  • Teachers Advisors's Esperion Therapeutics position peaked at $9.77M in Q4 2017.
  • 163 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.